Lucid Diagnostics Inc Sustainability Reports
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company focused on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer. The company develops and commercializes non-invasive diagnostic tests, including its flagship EsoGuard Esophageal DNA Test.
Sector: Healthcare & social services
Country: United States
Exchange: Nasdaq
FIGI: BBG012NYMM65
1 reports from 2023 to 2023
